SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing significant volatility and social media attention as investors debate its high-growth potential versus concerns over substantial cash burn and a challenging valuation heading into its quarterly earnings report. The community is actively discussing the company's recent commercial milestones and government contracts as indicators of long-term viability, while critics focus on the risks of share dilution and the sustainability of its financial position.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc is generating significant community interest ahead of its upcoming earnings call, with investors closely watching for a potential turnaround driven by improved cost discipline, subscription growth, and advancements in AR and AI integration. The stock is experiencing high volatility as participants weigh these long-term catalysts against ongoing concerns regarding user growth and intense competition in the social media space.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently experiencing high-volume momentum and aggressive buying as investors re-rate the stock amid the burgeoning AI infrastructure cycle and increasing demand for specialized CPU architecture. While bullish sentiment is fueled by institutional upgrades and a rotation toward CPU-centric compute stacks, the community is actively debating the stock's elevated valuation, with many cautious of a potential mean reversion given its rapid parabolic climb.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corporation is experiencing intense volatility driven by significant institutional selling of a major shareholder's stake, though community members are debating whether this marks a final clearance of supply or a signal of deeper structural concerns. While some investors view the current price action as a tactical accumulation opportunity ahead of upcoming earnings and potential sector-wide interest, others remain skeptical about management's ability to drive sustained profitability.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as investors react to a powerful earnings beat characterized by massive year-over-year growth and exceptional profit margins driven by its AI-powered AXON engine. While the stock faces volatility and community debate over its software sector classification, bullish sentiment remains centered on its aggressive e-commerce expansion and strong cash flow generation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and heavy short-interest pressure as investors weigh recent clinical data updates for its siRNA pipeline against ongoing regulatory uncertainties surrounding its core gene therapy franchise. While the community remains sharply divided, active discussions center on the company's attractive valuation relative to its revenue base and the potential for a short squeeze if upcoming earnings and regulatory filings provide the necessary momentum.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing significant volatility and a sharp price correction as the market digests recent competitive concerns and profit-taking after a sustained rally. The community remains deeply divided, with many traders debating whether this is a structural breakdown or a temporary pullback before the company's next earnings report, while others highlight the stock's resilience as an edge-computing infrastructure player.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is gaining significant momentum following NOAA's official ruling that its deep-seabed mining application is fully compliant, a key regulatory milestone that clears a path toward potential commercial operations by 2027. Community members are actively debating the stock's long-term potential as a critical player in U.S. mineral sovereignty and are closely watching for follow-up news regarding commercial agreements and federal permitting timelines.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is experiencing extreme volatility as investors weigh strong operational fundamentalsincluding a 200M share buyback and margin expansionagainst a controversial short report that the company has formally refuted. The community is actively debating the credibility of these allegations, with many viewing the sharp sell-off as a significant buying opportunity while others express frustration over the sustained pressure on the stock price.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is generating significant investor buzz following a strong quarterly earnings beat and the strategic divestiture of its SDX portfolio, which has left the company debt-free and well-positioned for future growth. Community discussions are heavily centered on the potential for an imminent buyout, with many highlighting the stock as a prime acquisition target now that legal and financial overhangs have been removed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMGN I like AMGN and other big biotechs long term, but wanted to alert you of a company reporting ER and pivotal news after close TODAY.  Tiny company (ICU) has the first meaningful improvement in treating Acute Kidney Injury in decades.  Already being used with children, and adults soon (50x market size). 
$9 Million MC, with a TAM in the Billions (read that again). 90% margins. 
Ramping up product which will become Standard of Care for a number of conditions involving hyper-inflammation and sepsis (AKI, Cardiorenal, burn victims, transplant patients, COVID/respiratory). 
Saves lives of AKI patients and ELIMINATES dialysis dependency. 
Total addressable market 2B-20B. 
Zero debt. 
Ample runway. 
Pivotal adult AKI study to be completed in 9 months. 
Being used at Mayo Clinic, Cinci Childrens, UCSF, Dallas Childrens, dozens more hospitals. 
6 (SIX!) Breakthrough Device Designations. 
So, 9M MC for a company that will be worth Billions in a few years. $BDX $PFE $MRNA $TAK

StockTwits Web

Larry

AMGEN Inc.

Becton, Dickinson And Co.

Pfizer Inc

Moderna Inc

Takeda Pharmaceutical Co Ltd (ADR)

 I like AMGN and other big biotechs long term, but wanted to alert you of a company reporting ER and pivotal news after close TODAY.  Tiny company (ICU) has the first meaningful improvement in treating Acute Kidney Injury in decades.  Already being used with children, and adults soon (50x market size). 
$9 Million MC, with a TAM in the Billions (read that again). 90% margins. 
Ramping up product which will become Standard of Care for a number of conditions involving hyper-inflammation and sepsis (AKI, Cardiorenal, burn victims, transplant patients, COVID/respiratory). 
Saves lives of AKI patients and ELIMINATES dialysis dependency. 
Total addressable market 2B-20B. 
Zero debt. 
Ample runway. 
Pivotal adult AKI study to be completed in 9 months. 
Being used at Mayo Clinic, Cinci Childrens, UCSF, Dallas Childrens, dozens more hospitals. 
6 (SIX!) Breakthrough Device Designations. 
So, 9M MC for a company that will be worth Billions in a few years. 